[1]覃睿,农文政,莫秋荣.多梳家族蛋白Bmi-1在妇科肿瘤中作用的研究进展[J].中国临床新医学,2019,12(12):1358-1361.
QIN R,NONG WZ,MO QR.Progress of research on polocomb group protein Bmi-1 in gynecological oncology[J].Chinese Journal of New Clinical Medicine,2019,12(12):1358-1361.
[2]ALNAFAKH RAA,ADISHESH M,BUTTON L,et al.Telomerase and telomeres in endometrial cancer[J].Frontiers in Oncology,2019,9(17):344.
[3]刘春灵,李晓莉,杨旭,等.Bmi-1和hTERT在乳腺癌细胞中的表达及与凋亡的关系[J].中国临床解剖学杂志,2014,32(1):61-66.
LIU CL,LI XL,YANG X,et al.Bmi-1、hTERT expression in breast cancer cells and its relation with apoptosis[J].Chinese Journal of Clinical Anatomy,2014,32(1):61-66.
[4]FIGO Committee on Gynecologic Oncology.FIGO staging for carcinoma of the vulva,cervix,and corpusuteri[J].Int J Gynaecol Obstet,2014,125(2):97-98.
[5]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin.2018,68(6):394-424.
[6]PANDITA P,WANG X,JONES DE,et al.Unique molecular features in high-risk histology endometrial cancers[J].Cancers(Basel),2019,11(11):1665.
[7]李晓东.Bmi-1在胃癌表达的临床意义及调控机制研究[D].江苏:苏州大学,2018.
LI XD.Clinical significance and regulatory mechanism of Bmi-1 expression in gastric cancer[D].Jiangsu:Suzhou University,2018.
[8]范中平,胡悦东,黄宝俊.胃癌中microRNA-218调控BMI1基因表达的作用及机制[J].中国现代医学杂志,2016,26(15):65-68.
FAN ZP,HU YD,HUANG BJ.Effect and mechanism of microRNA-218 in regulation of BMI1 gene in gastric cancer[J].China Journal of Modem Medicine,2016,26(15):65-68.
[9]HORIEK K,ISEKI C,KIKUCHI M,et al.Bmi-1 immunohistochemical expression in endometrial carcinoma is correlated with prognostic activity[J].Medicina(Kaunas),2020,56(2):72.
[10]ENGELSEN IB,MANNELQVIST M,STEFANSSON IM,et al.Low BMI-1 expression is associated with an activated BMI-1-driven signature,vascular invasion,and hormone receptor loss in endometrial carcinoma[J].British Journal of Cancer,2008,98(10):1662-1669.
[11]ZACZEK A,JOZWIAK P,CIESIEISKI P,et al.Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer[J].J Cell Mol Med,2020,24(2):1300-1310.
[12]BELL DW,ELLENSON LH.Molecular genetics of endometrial carcinoma[J].Annu Rev Pathol,2019,(24)14:339-367.
[13]曾丽霞,马韵.TERT启动子突变与尿路上皮肿瘤的研究进展[J].右江医学,2019,47(5):321-325.
ZENG LX,MA Y.Research progress of TERT promoter mutation in urothelial cancer[J].Chinese Youjiang Medical Journal,2019,47(5):321-325.
[14]LEAO R,APOLONIO JD,LEE D,et al.Mechanisms of human telomerase reverse transcriptase(hTERT) regulation clinical impacts in cancer[J].J Biomed Sci,2018,25(1):22.
[15]HAPANGAMA DK,KAMAML A,SARETZKI G.Implications of telomeres and telomerase in endometrial pathology[J].Hum Reprod Update,2017,23(2):166-187.
[16]胡占峰,李淑全,严鹏,等.Bmi-1和hTERT在结直肠癌组织中的表达和相关性[J].承德医学院学报,2015,32(2):93-95.
HU ZF,LI SQ,YAN P,et al.Expression and correlation of Bmi-1and hTERT in colorectal carcinoma[J].Journal of Chengde Medical College,2015,32(2):93-95.